VolitionRX Ltd [AMEX: VNRX] traded at a high on Wednesday, posting a 2.94 gain after which it closed the day’ session at $0.67.
The results of the trading session contributed to over 113608 shares changing hands. Over the past one week, the price volatility of VolitionRX Ltd stands at 8.92% while the volatility over the past one month is 4.62%.
The market cap for VNRX stock reached $69.15 million, with 100.75 million shares outstanding and 76.14 million shares in the current float. Compared to the average trading volume of 259.28K shares, VNRX reached a trading volume of 113608 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about VolitionRX Ltd [VNRX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VNRX shares is $2.90 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VNRX stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for VolitionRX Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 08, 2025. The new note on the price target was released on February 01, 2023, representing the official price target for VolitionRX Ltd stock. Previously, the target price had yet another drop from $8 to $7, while Cantor Fitzgerald kept a Overweight rating on VNRX stock.
The Average True Range (ATR) for VolitionRX Ltd is set at 0.06, with the Price to Sales ratio for VNRX stock in the period of the last 12 months amounting to 52.78.
How has VNRX stock performed recently?
VolitionRX Ltd [VNRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.35. With this latest performance, VNRX shares gained by 60.11% in over the last four-week period, additionally plugging by 18.80% over the last 6 months – not to mention a drop of -5.20% in the past year of trading.
VolitionRX Ltd [VNRX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and VolitionRX Ltd [VNRX] shares currently have an operating margin of -1846.75% and a Gross Margin at 1.50%. VolitionRX Ltd’s Net Margin is presently recorded at -1836.21%.
Return on Equity for this stock declined to -171.88%, with Return on Assets sitting at -171.88%.
Insider trade positions for VolitionRX Ltd [VNRX]
There are presently around $20.39%, or 25.01%% of VNRX stock, in the hands of institutional investors. The top three institutional holders of VNRX stocks are: LAGODA INVESTMENT MANAGEMENT, L.P. with ownership of 5.44 million shares, which is approximately 6.578%. VANGUARD GROUP INC, holding 0.64 million shares of the stock with an approximate value of $$0.39 million in VNRX stocks shares; and VANGUARD GROUP INC, currently with $$0.38 million in VNRX stock with ownership which is approximately 0.7676%.
